These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 19625522)
21. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. Garzon DJ; Fahnestock M J Neurosci; 2007 Mar; 27(10):2628-35. PubMed ID: 17344400 [TBL] [Abstract][Full Text] [Related]
22. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231 [TBL] [Abstract][Full Text] [Related]
23. Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease. Bilousova T; Taylor K; Emirzian A; Gylys R; Frautschy SA; Cole GM; Teng E Neurobiol Dis; 2015 Feb; 74():32-40. PubMed ID: 25449907 [TBL] [Abstract][Full Text] [Related]
24. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease. Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007 [TBL] [Abstract][Full Text] [Related]
25. Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease. Francis BM; Yang J; Hajderi E; Brown ME; Michalski B; McLaurin J; Fahnestock M; Mount HT Neuropsychopharmacology; 2012 Jul; 37(8):1934-44. PubMed ID: 22491352 [TBL] [Abstract][Full Text] [Related]
26. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Devi L; Ohno M Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882 [TBL] [Abstract][Full Text] [Related]
27. Exercise and BDNF reduce Aβ production by enhancing α-secretase processing of APP. Nigam SM; Xu S; Kritikou JS; Marosi K; Brodin L; Mattson MP J Neurochem; 2017 Jul; 142(2):286-296. PubMed ID: 28382744 [TBL] [Abstract][Full Text] [Related]
28. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
29. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600 [TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin Signaling can Rescue Cognition and Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease. Zhang Z; Yu Z; Yuan Y; Yang J; Wang S; Ma H; Hao L; Ma J; Li Z; Zhang Z; Hölscher C Mol Neurobiol; 2023 Sep; 60(9):5067-5089. PubMed ID: 37247071 [TBL] [Abstract][Full Text] [Related]
31. Early Candidate Urine Biomarkers for Detecting Alzheimer's Disease Before Amyloid-β Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model. Zhang F; Wei J; Li X; Ma C; Gao Y J Alzheimers Dis; 2018; 66(2):613-637. PubMed ID: 30320578 [TBL] [Abstract][Full Text] [Related]
32. Total flavonoid extract from Dracoephalum moldavica L. attenuates β-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways. Liu QS; Jiang HL; Wang Y; Wang LL; Zhang JX; He CH; Shao S; Zhang TT; Xing JG; Liu R Life Sci; 2018 Jan; 193():214-225. PubMed ID: 29100755 [TBL] [Abstract][Full Text] [Related]
33. Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model. Choi JH; Berger JD; Mazzella MJ; Morales-Corraliza J; Cataldo AM; Nixon RA; Ginsberg SD; Levy E; Mathews PM J Neurochem; 2009 Sep; 110(6):1818-27. PubMed ID: 19619138 [TBL] [Abstract][Full Text] [Related]
34. proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice. Chen J; Zhang T; Jiao S; Zhou X; Zhong J; Wang Y; Liu J; Deng J; Wang S; Xu Z J Alzheimers Dis; 2017; 59(3):941-949. PubMed ID: 28697556 [TBL] [Abstract][Full Text] [Related]
35. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. Rockenstein EM; McConlogue L; Tan H; Power M; Masliah E; Mucke L J Biol Chem; 1995 Nov; 270(47):28257-67. PubMed ID: 7499323 [TBL] [Abstract][Full Text] [Related]
36. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease. Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067 [TBL] [Abstract][Full Text] [Related]
38. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease. Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165 [TBL] [Abstract][Full Text] [Related]
39. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Caccamo A; Maldonado MA; Bokov AF; Majumder S; Oddo S Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22687-92. PubMed ID: 21149712 [TBL] [Abstract][Full Text] [Related]
40. 1H-MRS assessment of the therapeutic effect of bilateral intraventricular BDNF infusion into APP/PS1 double transgenic mice. Zhang W; Wang PJ; Li MH; Wang GL; Li P; Gao XL J Mol Neurosci; 2013 Jul; 50(3):434-42. PubMed ID: 23315172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]